What is the latest chlamydia and gonorrhea news in Europe?

Chlamydia and gonorrhea rates have been rising across parts of the EU, with growing concern about antibiotic resistance. In this episode, we explain current trends, testing guidance, and how sexually transmitted infections (STIs) are managed safely in Europe.

In this episode, we cover:

• What chlamydia and gonorrhea are (bacterial sexually transmitted infections)

• Current EU surveillance trends and resistance concerns

• Common symptoms — and why many cases are asymptomatic

• Who should consider testing (new partners, unprotected sex, symptoms)

• How testing works (NAAT swabs and urine tests)

• Recommended antibiotic treatments under European guidance

• Partner notification and retesting timelines

• When in-person sexual health clinic review is required

• Situations where prescription requests may be declined without testing

Doctors assess symptoms, exposure risk, pregnancy status, allergy history, and recent antibiotic use before prescribing. Empirical treatment may not be appropriate without testing in certain cases. Suspected pelvic inflammatory disease or testicular pain requires urgent in-person assessment.

This episode reflects how STI diagnosis and treatment decisions are reviewed within structured medical assessment in European telemedicine at Mobi Doctor.

Read the full medical guide here:

https://www.mobidoctor.eu/blog/chlamydia-and-gonorrhea-news